Health Condition 1: null- Hodgkins Lymphoma
Conditions
Interventions
Intervention1: nil: nil
Control Intervention1: nil: nil
Sponsors
Rajiv Gandhi Cancer Institute and Research Centre
Eligibility
Inclusion criteria
Inclusion criteria: patients with denovo hodgkins lymphoma diagnosed within January 1, 2014 and December 31,2016.
Exclusion criteria
Exclusion criteria: Patients who didnâ??t complete the planned first line therapy.Patients with secondary malignancy.Patients with transformed lymphoma.Patients infected with HIV.Patients infected with Hepatitis B or Hepatitis C virus.Patients with active infection of fungi, bacterial and viral at the time of diagnosis of lymphoma.Patients with autoimmune disorders (except Hashimotoâ??s Thyroiditis.)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the association of ALC/AMC ratio with remission status in Hodgkins lymphoma after first line treatment. To determine the association of ALC/AMC with survival (Overall survival, Progression Free Survival) in Hodgkins lymphoma. Timepoint: Outcomes will be analysed on completion of 5 years. | — |
Secondary
| Measure | Time frame |
|---|---|
| i. To determine various factors (Age, Gender, Comorbidities, LDH, extranodal sites, no of extranodal sites, presence of B-symptoms, involvement of Bone Marrow, presence of bulky disease, IPI risk classification, staging, interim response, final response, relapse) predicting disease outcome and survival.Timepoint: Outcomes will be analysed on completion of 5 years. | — |
Countries
India
Contacts
Public ContactShifa Siddiqui
Rajiv Gandhi Cancer Institute and Research Centre
Outcome results
None listed